January 13th 2025
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
January 13th 2025
January 10th 2025
January 9th 2025
January 8th 2025
January 5th 2025
January 1st 2025
December 31st 2024
December 29th 2024
January 12th 2025
January 7th 2025
November 30th 2024
November 27th 2024